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In cases of hypertrophic cardiomyopathy, the patho-
physiologic role of the systolic pressure gradient across
the left ventricular outflow tract is the subject of con-
tinued controversy. A patient with this disorder is de-
scribed whose symptoms and provokable intraventric-
ular gradient disappeared after inferior myocardial
infarction. Diastolic left ventricular pressures were es-
sentially unchanged, the isovolumic relaxation period
became prolonged and the ejection fraction decreased
Hypertrophic cardiomyopathy is a genetically influenced
disorder characterized by ventricular hypertrophy that is
often asymmetrically distributed (1,2) and microscopically
disorganized (1,3). A mid to late systolic murmur and an
intraventricular pressure gradient may be present at rest or
with provocation. However, because the left ventricle emp-
ties more completely and with higher peak flow than normal,
the existence of true obstruction to outflow has been ques-
tioned (4) and this controversy remains unsettled (5). Al-
though dyspnea, angina and syncope do not correlate di-
rectly with the intraventricular gradient (6), medical (7-9)
and surgical (10) interventions that palliate symptoms gen-
erally also reduce or abolish this dynamic pressure gradient.
The spontaneous clinical improvement after myocardial in-
farction in a patient with hypertrophic cardiomyopathy, with
concomitant reduction in obstructive manifestations, pro-
vides additional indirect evidence that the intraventricular
pressure gradient is not merely an epiphenomenon in this
disorder (5,11).
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from 0.77 to 0.61 after infarction. The peak ejection rate
was unchanged, but the disappearance of systolic an-
terior motion of the mitral valve leaflet and obstructive
manifestations may have resulted from enlarged mid to
late systolic ventricular volumes. This case suggests a
direct relation between symptoms and intraventricular
pressure gradient in certain patients with hypertrophic
cardiomyopathy.
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Case History
A 58 year old white man was readmitted to our facility
for reevaluation of hypertrophic cardiomyopathy. Six years
earlier, he had presented with a 2 year history of exertional
chest oppression, limb fatigue and dyspnea. The exertional
symptoms usually resolved after 30 minutes of rest; he also
experiencedpostural light-headednessand occasional syncope.
Clinical features. Physical examination featured a
prominent jugular A wave, bifid carotid pulse, double apical
impulse, prominent S4 and a grade 3/6 mid-systolic murmur
that increased with the Valsalva maneuver and decreased
with handgrip and squatting. The electrocardiogram showed
left atrial enlargement and prominent left ventricular hy-
pertrophy. M-mode echocardiography demonstrated asym-
metric septal hypertrophy and marked systolic anterior mo-
tion of the anterior mitral leaflet (Fig. 1).
Transseptal cardiac catheterization revealed mild ele-
vation in mean left atrial pressure, more prominent left
ventricular end-diastolic pressure elevation and a provokable
intraventriculargradient (Table 1). A 30° right anterior oblique
left ventricular cineangiogram showed a rapidly contracting
ventricle with an ejection fraction of 0.77, but without total
apical systolic obliteration or mitral regurgitation. Despite
a history of heavy smoking, the patient's coronary arteries
were normal except for mild irregularities including a 20%
narrowing of the left ventricular extension branch of the
dominant right coronary artery.
The patient received propranolol, 320 mg/day, along with
a thiazide diuretic drug for hypertension. However, he re-
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Figure 1. M-mode echocardiograms before (A)andafter(B)myo-
cardial infarction. In A, the dark arrows markmitral valve(MY)
systolic anterior motion, which coincides with the mid-systolic
murmur (SM). In B, the systolic anterior motion (open arrows)
and systolic murmur are absent. IYS = interventricular septum.
mained in New York Heart Association functional class III
because ofdyspnea and angina. His blood pressure generally
was 150/90 mm Hg on follow-up, and his murmur at rest
was unchanged during the drug therapy.
Clinical course after myocardial infarction. The pa-
tient remained clinically unchanged until 6 years after his
initial presentation, when he was admitted to another hos-
pital for severe crushing retrostemal chest pain. Inferior
myocardial infarction was diagnosed by electrocardio-
graphic Q waves, creatine kinase isoenzyme elevation and
technetium pyrophosphate scintigraphic scan. The hospital
course was uncomplicated, and he was discharged while
taking propranolol and a thiazide diuretic drug.
After recovering from his infarction, the patient stated
without prompting that his oppressive symptoms had van-
ished almost entirely. Only a "slight twinge of limb heav-
iness" occurred during heavy exertion, without the trou-
bling dyspnea or angina, allowing much improved exercise
tolerance. On admission 2 months after his infarction, phys-
ical examination revealed a palpable S4, normal carotid pulse
and no murmur at rest or with the Valsalva maneuver. The
electrocardiogram showed new deep inferior Q waves and
anterolateral T wave inversions. M-mode echocardiography
demonstrated complete disappearance of mitral systolic an-
terior motion (Fig. 1). Two-dimensional echocardiography
clearly showed mitral leaflet coaptation at the midportion
of the anterior leaflet (12), with the distal anterior leaflet
freely floating in the left ventricle but not moving toward
the septum during systole. Propranolol was withheld for 24
hours, and repeat transseptal cardiac catheterization showed
essentially unchanged diastolic pressures and no provokable
intraventricular gradient (Table I). The repeat 30° right an-
terior oblique left ventricular angiogram showed an infer-
obasal dyskinetic segment, an ejection fraction of 0.61 and
no mitral regurgitation. Coronary angiography showed a
new subtotal occlusion in the left ventricular extension branch
of the right coronary.
Data analysis. Frame by frame left ventricular volumes
were calculated with a lightpen-accessed Dodge area-length
program (two tracings averaged for each frame), and the
first well opacified beat was analyzed in the pre- and post-
infarction studies (Fig. 2). There was no ventricular ar-
rhythmia during either cineangiogram, but poorly defined
aortic valve closure did not allow definition of end-systole.
In addition, the isovolumic relaxation time was measured
from the first high frequency component of Sz to the point
of initial rapid mitral opening on simultaneous phonocar-
diography and echocardiography, averaged over four beats
and rounded to the nearest 10 ms before and after infarction
(Fig. 1, Table 1).
Discussion
Arguments for obstruction to outflow. The constel-
lation of dyspnea, angina, syncope, systolic murmur, asym-
metric septal hypertrophy, systolic anterior motion of the
mitral valve and provokable intraventricular gradient in this
patient is typical of hypertrophic cardiomyopathy (11). In
the preinfarction basal state, the peak left ventricular ejec-
tion rate was elevated (Fig. 2, Table 1). Careful electro-
magnetic flow probe and angiographic studies (13) have
demonstrated similarly elevated peak ejection rates in cases
of hypertrophic cardiomyopathy with or without an intra-
ventricular pressure gradient at rest, and these findings have
been interpreted as evidence against true obstruction to out-
flow. A comprehensive account of hypertrophic cardio-
myopathy, however, must acknowledge that the systolic
pressure in nonobliterated portions of the left ventricle may
be far in excess of that in the outflow tract or aorta during
lACC Vol. 5. No.3
March 1985:797-802
CAPLAN ET AL.
INFARCTION IN HYPERTROPHIC CARDIOMYOPATHY
799
Table 1. Hemodynamic Profile in Patient With Hypertrophic Cardiomyopathy Before and After
Myocardial Infarction
Initial Study Postinfarction
Pressure (mm Hg)
Left atrium (A wavelV wave [mean])
Control
Left ventricle (systolic/mid-diastolic/end-diastolic)
Aorta (systolic/diastolic)
Valsalva (phase 2)
Left ventricle (systolic)
Aorta (systolic/diastolic)
Isoproterenol infusion (heart rate [beats/min])
Left ventricle (systolic/mid-diastolic/end-diastolic)
Aorta (systolic/diastolic)
Maximal intraventricular gradient
Rest heart rate (beats/min)
Cardiac index (liters/min per rrr')
Left ventricular ejection fraction
Peak ejection rate (mils)
Isovolumic relaxation time (ms)
25/15 [14)
178116/24
1741110
202
1301100
(82~98)
270/20/35
140/100
l72t
82
2.7
0.77
480
40
32/18 [15]
165114127
180/95*
150
150/100
(6~108)
148/10/16
1481100
O:j:
60
1.9
0.61
450
100
*Femoral artery pressure; tpremarure ventricular complex during the Valsalva maneuver; :j:including pre-
mature ventricular complex and Valsalva maneuvers during isoproterenol infusion.
Figure 2. Angiographic left ventricular volume-time curves be-
fore and after myocardial infarction.
a portion of ventricular ejection (14). In this case, for in-
stance, the preinfarction left ventricular peak systolic pres-
sure carefully measured just within the mitral inlet was 270
mm Hg during isoproterenol infusion compared with an
aortic systolic pressure of 140 mm Hg. According to basic
hydraulic principles, such a pressure gradient during flow
reflects an abnormal resistance to ejection (15). Because a
portion of ejection occurs before a high outflow gradient is
reached, the effect on stroke work (as estimated by the time
average of instantaneous ejection volume times outflow gra-
dient) is less than that due to a fixed obstruction (16). In
support of obstruction, nevertheless, is that the time required
to complete ejection tends to be longer with than without
an intraventricular gradient (13), in the extreme case man-
ifesting with reversed splitting of S2 (6,17), and several
methods of measurement show a low magnitude plateau
after the early peak in aortic flow (16,18,19).
Systolic phenomena. The systolic pressure within the
body of the left ventricle may be strikingly elevated, but
when expressed as systolic wall stress (for example, equa-
torial midwall), instantaneous left ventricular load depends
on ventricular geometry as well as the intracavitary pressure
(20). Simplified geometric assumptions are not readily ap-
plicable in the asymmetrically hypertrophied ventricle, but
both an increase in mean wall thickness and a decrease in
ventricular radius presumably would reduce systolic stress
for a given ventricular pressure (21). Because patients with
an intraventricular gradient at rest tend to have more gen-
eralized hypertrophy than do those without (2), the unload-
ing effect of such hypertrophy may help explain the com-
parable peak rate and completeness of ejection in the two
groups (13,21). Indeed, certain patients with fixed aortic
stenosis have a supernormal ejection fraction (22,23), pre-
sumably because hypertrophy reduces systolic ventricular
stress (23) .
Marked elevation of systolic ventricular pressure may
have other consequences. For instance, reflex changes due
to elevated ventricular pressure may playa role in syncope,
as suggested in cases of aortic stenosis (24). Furthermore,
because coronary flow reserve may be reduced in hyper-
trophic states (25), the moderate effects of dynamic obstruc-
tion on stroke work and myocardial oxygen requirements
may be sufficient to produce ischemia. Angina and dyspnea
sometimes exist in the absence of a demonstrable intra-
ventricular gradient (6), but our patient's symptoms im-
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proved dramatically with the disappearance of the provok-
able gradient, suggesting a causal relation in some instances .
In a study (26) of 126 patients with hypertrophic cardio-
myopathy, the average intraventricular gradient was signif-
icantly higher in those in functional classes III and IV than
in those in classes I and n. In cases of fixed aortic stenosis,
there is also only a rough correlation between the transaortic
gradient and symptoms (27), suggesting that other variables
such as coronary flow reserve have an important effect (25) .
Diastolic abnormalities. Long recognized diastolic ab-
normalities in cases of hypertrophic cardiomyopathy have
received recent emphasis (5, II ,28-31) . Normal to reduced
diastolic ventricular volumes exist at elevated diastolic pres-
sures, owing perhaps to the effects of increased wall thick-
ness and abnormal relaxation on the diastolic pressure-vol-
ume relation (29,30,32). Although left ventricular end-
diastolic pressure at rest is often elevated, there is poor
correlation with functional class (26), and the mid-diastolic
pressure, which better correlates with pulmonary conges-
tion, mayor may not be elevated. In this patient, for in-
stance, the mean left atrial pressure at rest was mildly el-
evated both before and after infarction.
A prolonged isovolumic relaxation time has been cited
as evidence of abnormal ventricular relaxation (29,30) and
found to correlate roughly with the presence of angina (29).
However, this time interval depends on the aortic- and mi-
tral-left ventricular pressure crossover points, as well as on
the ventricular pressure decay time. In a recent study (17)
of 84 patients with hypertrophic cardiomyopathy, the iso-
volumic relaxation period varied widely from 0 to 160 ms,
overlapping considerably with the normal range of 40 to 80
rns, and correlated poorly with symptoms. Reversed split-
ting of S2 was found in the subset in which this interval was
abnormally shortened; the delay in aortic closure correlated
with a delay in left ventricular-aortic pressure crossover in
the setting of a large intraventricular gradient, attesting to
the reality and obstructive implications of such a gradient
(17) . In our patient, the isovolumic relaxation period was
normal in the symptomatic preinfarction state, but somewhat
prolonged after symptoms disappeared after infarction (Ta-
ble I) , perhaps influenced by the reduction in heart rate
(33). Thus, characterizing diastolic abnormalities in hyper-
trophic cardiomyopathy is difficult , and a simple variable
like the isovolumic relaxation period shows no better cor-
relation with symptoms than does the intraventricular pres-
sure gradient.
Mechanism of obstruction. Production of the intra-
ventricular pressure gradient appears to require systolic an-
terior motion of mitral valve tissue and septal contact (34,35).
The distal portion of the anterior mitral leaflet often appears
very loosely tethered (12), as in this case, and may be
particularly susceptible to Venturi forces near the septum
during the rapid phase of ejection (36). The mechanism of
mitral systolic anterior motion is poorly understood, but
because it occurs in hyperdynamic as well as hypertrophic
states (37), a reduced ventricular systolic volume and a high
early ejection rate are apparently needed. Understandably,
these paradoxic requirements for a dynamic obstructive
mechanism have led to conceptual difficulties, and they
emphasize the fundamental differences with fixed outflow
obstruction. In this patient, the peak flow rate was essentially
unchanged after infarction, but the increase in mid- to end-
systolic volumes may have prevented the provokable in-
traventricular gradient. The position of the posteromedial
papillary muscle also may have been altered by the adjacent
inferobasal infarction, but because loose tethering of the
distal anterior mitral leaflet persisted after infarction, this
potential effect was probably not important.
Related case reports. Although coronary artery disease
and hypertrophic cardiomyopathy can coexist (38), some
authorities (II) have been impressed by the rarity of this
association. We are aware of only two other reports in which
the provokable intraventricular gradient disappeared after
infarction (39,40) ; in neither case was a symptomatic change
mentioned. The traditional view that the hypertrophied sep-
tum is akinetic has been questioned (41), and in one of these
cases an anteroseptal infarct resulted in a loss of obstructive
manifestations (40) . Our patient received a thiazide diuretic
drug on a long-term basis for concomitant hypertension.
Although the attendant decrease in vascular volume con-
ceivably may exacerbate obstructive manifestations (16),
there was no clinical evidence for such an adverse effect.
Thiazide diuretic drugs cause only a 10 to 15% reduction
in plasma volume (42) and, aside from a case involving
both digitalis and diuretic drugs (43), we are unaware of
reports detailing clinical deterioration in cases of hyper-
trophic cardiomyopathy as a result of diuretic drugs.
Therapeutic considerations. In the absence of an ideal
therapy that reverses the underlying hypertrophic process,
medical therapy palliates symptoms by reducing the ino-
tropic state (7-9) or improving diastolic performance (31).
Septal myectomy appears to be superior in reducing symp-
toms, but the high rates of morbidity and mortality are
prohibitive (44), especially because there is little if any
impact on the occurrence of subsequent sudden death (44,45).
Maximal medical management , therefore, should be given
before considering the surgical method (44). Diastolic ven-
tricular pressures may sometimes be reduced, but the chief
palliative mechanism of myectomy appears to be abolish-
ment of the intraventricular gradient (10). In view of this
and other cases (39,40), the possibility that controlled in-
farction with temporary coronary artery balloon occlusion
may provide another palliative modality is intriguing and
deserves further study. Aside from troublesome conceptual
problems that remain, a large body of direct and indirect
observation suggests a pathophysiologic role for the intra-
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ventricular pressure gradient in hypertrophic cardio-
myopathy. Therapies that have an impact on this facet of
the disorder will continue to play an important part in its
treatment .
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